# 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

> **NCT04081701** · PHASE4 · RECRUITING · sponsor: **Weill Medical College of Cornell University** · enrollment: 200 (estimated)

## Conditions studied

- CNS Tumors
- Meningioma
- Esthesioneuroblastoma
- Hemangioblastoma
- Medulloblastoma
- Paraganglioma
- Pituitary Adenoma

## Interventions

- **DIAGNOSTIC_TEST:** Ga68-DOTATATE-PET/MRI

## Key facts

- **NCT ID:** NCT04081701
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-04
- **Primary completion:** 2038-12-31
- **Final completion:** 2038-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04081701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04081701, "68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04081701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*